Skip to main content

Table 1 Prevalence of RPP target respiratory pathogens among SARS-CoV-2-positive and -negative specimens

From: Broad respiratory testing to identify SARS-CoV-2 viral co-circulation and inform diagnostic stewardship in the COVID-19 pandemic

RPP targets detected SARS-CoV-2 detected
(n = 1 141)
SARS-CoV-2 not detected
(n = 51 129)
% # % #
0 96.6 1102 88.7 45,359
1 3.3 38 10.6 5408
2 0.1 1 0.7 340
3 - 0  < 0.1 17
4 - 0  < 0.1 5
  1. RPP Respiratory Pathogen Panel, NAT nucleic acid test. Fifteen specimens are not shown: 13 where patient demographics could not be verified, one due to an error in both the SARS-CoV-2 NAT and the RPP, and one where the SARS-CoV-2 test internal control failed. Of these 15, 14 were negative for all RPP targets, and one resulted in an error for both the RPP and SARS-CoV-2 tests